Financial News
Diagnos Inc (TSV:ADK)
Price and Volume
Detailed Quote| Volume | 119,750 |
| Open | 0.4850 |
| Bid (Size) | 0.4800 (115) |
| Ask (Size) | 0.4850 (170) |
| Prev. Close | 0.4750 |
| Today's Range | 0.4700 - 0.4850 |
| 52wk Range | 0.1750 - 0.5300 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
9.4% below 52-week high
0.4800
0.1752W Low
0.5352W High
1 Week
4.0% below 1-week high
0.471W Low
0.501W High
Diagnos Inc (ADK) traded between $0.17 and $0.53 over the past 52 weeks and last traded at $0.48, 9.4% below its 52-week high. Over the past week it ranged between $0.47 and $0.50.
Past 12 Months
1W
1M
3M
+$0.21
6M
+$0.21
YTD
+$0.12
1Y
+$0.15
ADK was +47.7% over the past year, +77.8% over six months, +33.3% year to date.
12 Months vs Market
ADK
+47.7%
DIA
+9.3%
SPY
+15.0%
QQQ
+24.3%
IWM
+14.5%
Over the past 12 months ADK returned +47.7% versus DIA (Dow) +9.3%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +14.5%.
Volume & Liquidity
0.41× 3-mo avg
Today 119,750
3-mo avg 291.2K
1W
214.9K
1M
226.3K
3M
291.2K
6M
250.3K
YTD
223.8K
1Y
246.1K
ADK most recently traded 119,750 shares against a 3-month average daily volume of 291.2K.
More News
Read MoreFrequently Asked Questions
Is Diagnos Inc publicly traded?
Yes, Diagnos Inc is publicly traded.
What exchange does Diagnos Inc trade on?
Diagnos Inc trades on the Toronto Venture Stock Exchange
What is the ticker symbol for Diagnos Inc?
The ticker symbol for Diagnos Inc is ADK on the Toronto Venture Stock Exchange
What is the current price of Diagnos Inc?
The current price of Diagnos Inc is 0.4800
When was Diagnos Inc last traded?
The last trade of Diagnos Inc was at 10/02/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
